- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 5, 2025 | 22.33M sh |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $2.64M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $2.17M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $286.99M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $333.73M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $776.78M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $812.47M |
| Eps Diluted | Q2 2025 · Mar 31, 2025 | $0.50 |
| Eps Diluted | Q2 2025 · Mar 31, 2025 | $1.00 |
| Eps Diluted restated | Q2 2025 · Mar 31, 2024 | $0.49 |
| Eps Diluted restated | Q2 2025 · Mar 31, 2024 | $1.04 |
| Eps Basic | Q2 2025 · Mar 31, 2025 | $0.50 |
| Eps Basic | Q2 2025 · Mar 31, 2025 | $1.00 |
| Eps Basic restated | Q2 2025 · Mar 31, 2024 | $0.49 |
| Eps Basic restated | Q2 2025 · Mar 31, 2024 | $1.04 |
| Shares Diluted restated | Q2 2025 · Mar 31, 2024 | 21.75M sh |
| Shares Diluted restated | Q2 2025 · Mar 31, 2024 | 21.75M sh |
| Dividends Paid | Q2 2025 · Mar 31, 2024 | $21.54M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$45.28M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $430.79M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $417.93M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $408.7M |
| Net Income | Q2 2025 · Mar 31, 2024 | $23.63M |
| Net Income | Q2 2025 · Mar 31, 2024 | $43.63M |